Photoelectron expands Photon Radiosurgery System brain tumor treatment trials.
This article was originally published in The Gray Sheet
Executive SummaryPHOTOELECTRON CORP.'S PHOTON RADIOSURGERY SYSTEM CLINICAL TRIALS are being expanded with the addition of two clinical sites, the University of Southern California at Los Angeles and University of California at San Francisco. The sites are expected to begin enrolling patients by the end of February. Three other U.S. sites -- Massachusetts General Hospital and Brigham and Women's Hospital in Boston and the Memorial Sloan-Kettering Cancer Center in New York City -- already are participating in the study, which is evaluating the Photon Radiosurgery System as a treatment for brain tumors.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.